Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Credit: CDC

Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

The findings are an important step toward a potential new weapon in the fight against a that affects millions of people around the globe, with nearly 80 million new cases estimated each year.

The pathogen that causes the disease, Neisseria gonorrhoeae, is considered a "superbug" because of its resistance to all classes of antibiotics available for treating infections.

Gonorrhea is highly damaging to reproductive and neonatal health if untreated or improperly treated. It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Also, babies born to infected mothers are at increased risk of blindness.

More than half of infected women don't have symptoms, but those asymptomatic cases can still lead to severe consequences for the patient's reproductive health, including miscarriage or premature delivery, said OSU College of Pharmacy researcher Aleksandra Sikora.

Subjecting N. gonorrhoeae to the phenotypic microarray screening method for the first time, Sikora's team focused on seven proteins from the bacteria's cell envelope, which consists of the outer membrane, the cell wall and the inner membrane.

Phenotypic microarrays are a high-throughput system featuring plates with 96 wells per plate, each well representing a different condition under which to research the phenotypes—the observable characteristics—of the examined mutants.

The goal was to see which if any of the seven proteins would show strong potential as a antigen—a molecule that sends the immune system into action. Vaccines prevent disease because the antigens they contain trigger an immune response that allows antibodies to recognize and attack pathogens to prevent future infection.

"Proteins in the cell envelope play key roles in cell function and bacterial physiology," Sikora said. "That and their location make them attractive candidates for developing vaccines. But a lot of them are hypothetical proteins—we know bacteria have them but we don't know for sure how they function. Learning what they contribute to cell structure, permeability, membrane biogenesis and so on is important in vaccine research because antibodies against protein antigens can disable the 's function."

In all, more than 1,000 conditions were used to study the effects of knocking out each of the seven proteins.

"It's like a football coach trying to choose the top quarterback among seven candidates by looking at their performance on many different teams during many different games," Sikora said. "Imagine being able to look at those seven quarterbacks in over a thousand different games simultaneously. Of course, that's not possible with football, but this is what we are doing here to identify the most promising vaccine candidates."

Researchers found 91 conditions that had uniquely positive or negative effects on one of the mutants, and a cluster analysis of 37 commonly beneficial compounds and 57 commonly detrimental compounds revealed three separate phenotype groups.

Two of the proteins, NGO1985 and NGO2121, showed extensive sensitivity to antimicrobial compounds and thus emerged as the most promising vaccine candidates. This study serves as a jumping-off point for further characterization of proteins in the cell envelope.

"Neisseria gonorrhoeae is a difficult bacteria to work with, and it's very diverse," Sikora said. "It has great genome plasticity—there are huge variations between strains. Phenotypic screening allows us to see how similar and how different they are."

Explore further: New gonorrhea treatment targets enzyme needed for respiration

More information: Benjamin I. Baarda et al, Deciphering the Function of New Gonococcal Vaccine Antigens Using Phenotypic Microarrays, Journal of Bacteriology (2017). DOI: 10.1128/JB.00037-17

Related Stories

New gonorrhea treatment targets enzyme needed for respiration

June 26, 2017
Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

Proteins discovered in gonorrhea may offer new approach to treatment

March 31, 2014
Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased ...

Gonorrhea manipulates an anti-infection mechanism in the female reproductive tract

April 13, 2017
The bacterium that causes gonorrhea infects the female reproductive tract by breaking connections between cells in the tract's protective lining, according to new research published in PLOS Pathogens.

New antibiotic class found effective against gonorrhea in the laboratory

August 7, 2017
The World Health Organisation (WHO) has estimated that 700,000 people around the world die annually from drug resistant infections. It also listed drug resistant gonorrhoea, a sexually transmitted disease caused by the Neisseria ...

Discovery of a Zika antibody offers hope for a vaccine

May 4, 2017
A research team based at The Rockefeller University has identified a potent new weapon against the Zika virus in the blood of people who have been infected by it. This discovery could lead to new ways of fighting the disease, ...

Recommended for you

Exploring how herpes simplex virus changes when passed between family members

October 22, 2017
A new study explores how herpes simplex virus might change when passed from one individual to another, information that may prove useful in future development of therapeutics and vaccines. This rare glimpse into a transmission ...

Pneumonia vaccine under development provides 'most comprehensive coverage' to date, alleviates antimicrobial concerns

October 20, 2017
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.

Newly discovered viral marker could help predict flu severity in infected patients

October 20, 2017
Flu viruses contain defective genetic material that may activate the immune system in infected patients, and new research published in PLOS Pathogens suggests that lower levels of these molecules could increase flu severity.

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.